ArticleCancer biology & therapy2024

NAALADL2-AS2 functions as a competing endogenous RNA to regulate apoptosis and drug resistance in DLBCL.

Xiaoli Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.